Skip to main content

Table 2 Patient medications and co-morbidities

From: Cholinergic Anti-Inflammatory Pathway Activity and High Mobility Group Box-1 (HMGB1) Serum Levels in Patients with Rheumatoid Arthritis

   ACR Duration of   
Gender Age Criteria RA (years) Smoking RA Tx
M/F=4/9 Avg = 52.7 Median=52     
F 54 Y 4 n Sulfasalazine
F 63 Y 5 n TNF-alpha blocker
F 47 Y 10 n TNF-alpha blocker p ]Methotrexate Prednisone
F 55 Y 6 n TNF-alpha blocker Methotrexate Folic Acid
F 52 Y 17 n TNF-alpha blocker Methotrexate Folic Acid Hydroxychloroquine NSAIDS
F 38 Y 3 n Hydroxychloroquine
M 51 Y 16 n TNF-alpha blocker Prednisone
F 58 Y 10 n Hydroxychloroquine Prednisone
M 46 Y 16 n TNF-alpha blocker Methotrexate Folic Acid Prednisone
F 38 Y 10 n Methotrexate Prednisone NSAIDs
F 32 Y 5 n Sulfasalazine Methotrexate Folic Acid Prednisone
M 70 Y 31 n TNF-alpha blocker Methotrexate Folic Acid Prednisone
M 82 Y 3 n NSAIDs